| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 24.26B | 23.03B | 21.73B | 19.08B | 17.94B |
| Gross Profit | 6.77B | 9.40B | 8.93B | 8.03B | 7.01B |
| EBITDA | 8.79B | 8.18B | 7.94B | 7.17B | 9.38B |
| Net Income | 2.77B | 2.46B | 2.33B | 2.17B | 1.71B |
Balance Sheet | |||||
| Total Assets | 116.57B | 107.78B | 101.86B | 95.35B | 133.01B |
| Cash, Cash Equivalents and Short-Term Investments | 1.15B | 357.00M | 445.00M | 407.00M | 672.00M |
| Total Debt | 50.55B | 46.65B | 44.01B | 40.05B | 34.54B |
| Total Liabilities | 87.77B | 80.86B | 76.10B | 70.61B | 98.22B |
| Stockholders Equity | 28.80B | 26.92B | 25.75B | 24.74B | 34.39B |
Cash Flow | |||||
| Free Cash Flow | -2.27B | -1.53B | -2.71B | -2.28B | -4.97B |
| Operating Cash Flow | 6.25B | 5.57B | 4.70B | 4.87B | 3.01B |
| Investing Cash Flow | -8.53B | -7.04B | -7.38B | -6.99B | -3.32B |
| Financing Cash Flow | 2.53B | 1.31B | 2.68B | 1.59B | 758.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $68.84B | 19.11 | 12.33% | 3.25% | 7.66% | 37.42% | |
71 Outperform | $97.39B | 19.81 | 9.74% | 3.61% | 4.80% | 14.44% | |
70 Outperform | $190.06B | 27.63 | 13.05% | 2.84% | 26.96% | -6.80% | |
69 Neutral | $100.24B | 23.13 | 12.54% | 3.40% | 9.40% | -6.05% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
65 Neutral | $48.32B | 17.27 | 9.94% | 3.68% | 6.07% | 15.20% | |
65 Neutral | $55.27B | 22.02 | 9.27% | 4.59% | 12.72% | 4.90% |
On February 20, 2026, Exelon Corporation issued and sold $775 million in aggregate principal amount of 4.950% Notes due 2036, expanding its long-term debt profile. The transaction underscores the company’s continued access to capital markets and may support ongoing investment needs or refinancing activities, with implications for its balance sheet management and financing costs over the coming decade.
The most recent analyst rating on (EXC) stock is a Hold with a $51.00 price target. To see the full list of analyst forecasts on Exelon stock, see the EXC Stock Forecast page.
Exelon on Feb. 12, 2026 reported fourth-quarter and full-year 2025 results showing GAAP net income of $0.58 per share and adjusted operating earnings of $0.59 per share for the quarter, yielding full-year GAAP earnings of $2.73 and adjusted earnings of $2.77 per share, up from 2024 despite a modest year-on-year dip in quarterly profit. The company cited higher regulated utility earnings driven by distribution and transmission rate increases, favorable weather at PECO and elevated capital investment, partly offset by higher taxes, interest, depreciation and holding-company costs, including contributions to its Customer Relief Fund.
Management highlighted a $41.3 billion four-year capital expenditure plan expected to deliver 7.9% rate base growth and place operating EPS growth near the top of its 5%–7% target range through 2029, supported by an updated financing strategy that contemplates $3.4 billion of equity issuance over four years. Exelon also initiated 2026 adjusted earnings guidance of $2.81–$2.91 per share and noted that all its utilities achieved first-quartile reliability performance on industry outage metrics, reinforcing its grid-modernization narrative and signaling continued balance between shareholder returns, infrastructure spending and customer affordability.
The most recent analyst rating on (EXC) stock is a Buy with a $55.00 price target. To see the full list of analyst forecasts on Exelon stock, see the EXC Stock Forecast page.
On December 4, 2025, Exelon Corporation completed the sale of $1 billion in Convertible Senior Notes due 2029, which included a $100 million option for additional Notes. These Notes, offered to qualified institutional buyers, bear a fixed interest rate of 3.25% and are convertible into cash or a combination of cash and shares of Exelon’s common stock. The proceeds, estimated at $987.5 million, will be used to repay or refinance debt or for general corporate purposes. This strategic financial move positions Exelon to manage its debt effectively while maintaining flexibility in its capital structure, potentially impacting its market standing and stakeholder interests.
The most recent analyst rating on (EXC) stock is a Sell with a $43.00 price target. To see the full list of analyst forecasts on Exelon stock, see the EXC Stock Forecast page.
On November 26, 2025, Exelon Corporation announced the departure of David Glockner, Executive Vice President of Compliance, Audit, and Risk, effective January 1, 2026. Following his departure, Jeanne Jones will expand her role to include audit and risk responsibilities, while Colette Honorable will take on compliance duties, reflecting a strategic realignment of executive roles within the company.
The most recent analyst rating on (EXC) stock is a Hold with a $52.00 price target. To see the full list of analyst forecasts on Exelon stock, see the EXC Stock Forecast page.
On November 18, 2025, the United States District Court for the Northern District of Illinois granted preliminary approval for a proposed settlement of a consolidated stockholder derivative action involving Exelon Corporation. The settlement, reached through mediation by the Special Litigation Committee and the Independent Review Committee of Exelon’s Board, aims to resolve claims related to alleged breaches of fiduciary duty and other violations by Exelon’s officers and directors. The court’s approval of this settlement could impact Exelon’s operations and its stakeholders, as it addresses past legal challenges and aims to prevent future litigation related to these claims.
The most recent analyst rating on (EXC) stock is a Hold with a $52.00 price target. To see the full list of analyst forecasts on Exelon stock, see the EXC Stock Forecast page.